Translating the renoprotective effects of SGLT2 inhibitors to the diabetic retina

被引：0
|
作者：
Varughese, Maria S. [1 ]
Varadhan, Lakshminarayanan [2 ,3 ]
机构：
[1] Univ Sheffield, Sch Med & Populat Hlth, Sheffield, S Yorkshire, England
[2] Univ Hosp North Midlands NHS Trust, Stoke On Trent, N Staffs, England
[3] Keele Univ, Sch Med, Fac Hlth, Keele, N Staffs, England
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2025年
关键词：
SGLT2; inhibitors; diabetic nephropathy; diabetic retinopathy;
D O I：
10.1177/11206721251327647
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] SGLT2 inhibitors: diabetic ketoacidosis in the surgical setting
    Reactions Weekly, 2020, 1789 (1) : 10 - 10
  • [42] SGLT2 inhibitors and diabetic ketoacidosis — a growing concern
    Guillermo E. Umpierrez
    Nature Reviews Endocrinology, 2017, 13 : 441 - 442
  • [43] SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
    Kawanami, Daiji
    Matoba, Keiichiro
    Takeda, Yusuke
    Nagai, Yosuke
    Akamine, Tomoyo
    Yokota, Tamotsu
    Sango, Kazunori
    Utsunomiya, Kazunori
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (05)
  • [44] Adenosine Signal Plays an Important Role in Renoprotective Effects of SGLT2 Inhibitor in Proteinuric Diabetic Mice
    Shimada, Keiji
    Takagaki, Yuta
    Kanasaki, Keizo
    Koya, Daisuke
    DIABETES, 2019, 68
  • [45] SGLT2 inhibitors: diabetic kidney disease and beyond
    Staruschenko, Alexander
    Bhalla, Vivek
    Rangaswami, Janani
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2020, 319 (05) : F780 - F781
  • [46] Strengthened diabetic ketoacidosis warning for SGLT2 inhibitors
    Reactions Weekly, 2018, 1713 (1) : 3 - 3
  • [47] Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu
    Yaribeygi, Habib
    Maleki, Mina
    Reiner, Zeljko
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [48] Effects of SGLT2 Inhibitors on Cardiac Mechanics in Hispanic and Black Diabetic Patients
    Moras, Errol
    Shrivastav, Rishi
    Gandhi, Kruti D.
    Bandyopadhyay, Dhrubajyoti
    Isath, Ameesh
    Goel, Akshay
    Bella, Jonathan N.
    Contreras, Johanna
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [49] SGLT2 INHIBITORS
    Brito, M.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E162 - E162
  • [50] ANTIATHEROSCLEROTIC EFFECTS OF SGLT2 INHIBITORS IN TYPE 2 DIABETIC PATIENTS WITH OBESITY AND HYPERTENSION
    Yamagishi, T.
    ATHEROSCLEROSIS, 2018, 275 : E62 - E62
12345